<table id="id_6a2d1869-faf0-4346-b99e-4d9e0116c952" xmlns="urn:hl7-org:v3" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance">
<col align="left" width="25%"></col>
<col align="left" width="75%"></col>
<thead>
<tr id="id_489a9c63-3a2c-404a-81b5-b12334e0f65c" stylecode="Botrule">
<td align="left" stylecode="Lrule Rrule" valign="top">Interacting Drug</td>
<td align="left" stylecode="Rrule" valign="top">Interaction</td>
</tr>
</thead>
<tbody>
<tr id="id_64b1bfd7-62d2-4120-8044-c3e3bec19c49" stylecode="Toprule">
<td align="left" stylecode="Lrule Rrule" valign="top">Multivalent cation-containing products including antacids, metal cations or didanosine</td>
<td align="left" stylecode="Rrule" valign="top">Absorption of levofloxacin is decreased when the tablet or oral solution formulation is taken within 2 hours of these products. Do not co-administer the intravenous formulation in the same IV line with a multivalent cation, e.g., magnesium (<linkhtml href="#i4i_section_id_bbed9c6e-51bb-4b0a-8914-8816dc5147f5">2.4</linkhtml>, <linkhtml href="#i4i_section_id_a2560d91-eb4c-4b5e-957b-92f1cf860aec">7.1</linkhtml>)</td>
</tr>
<tr id="id_fada8ea4-35b0-4d73-9ca7-8c8f95531ff2">
<td align="left" stylecode="Lrule Rrule" valign="top">Warfarin</td>
<td align="left" stylecode="Rrule" valign="top">Effect may be enhanced. Monitor prothrombin time, INR, watch for bleeding (<linkhtml href="#i4i_section_id_c0a58582-207d-4802-a997-1b2ce3aefea3">7.2</linkhtml>)</td>
</tr>
<tr id="id_9af4840e-6dec-4094-ae45-3510fa758a59" stylecode="Botrule">
<td align="left" stylecode="Lrule Rrule" valign="top">Antidiabetic agents</td>
<td align="left" stylecode="Rrule" valign="top">Carefully monitor blood glucose (<linkhtml href="#i4i_section_id_0056bb0e-e426-45de-bb1d-80bc911454d4">5.10</linkhtml>, <linkhtml href="#i4i_section_id_ec2b240c-62c1-4b20-90b3-8b455910f455">7.3</linkhtml>)</td>
</tr>
</tbody>
</table>